Joseph D Feuerstein
Overview
Explore the profile of Joseph D Feuerstein including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
2690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klemm N, Feuerstein J
Expert Rev Gastroenterol Hepatol
. 2025 Feb;
:1-11.
PMID: 39987913
Introduction: Stricturing Crohn's disease is a common phenotype and treatment aims to improve symptoms, prevent complications, assess for proximal bowel disease activity, and screen for upstream neoplasm. Management is challenging...
2.
Flynn D, Feuerstein J
World J Gastroenterol
. 2024 Nov;
30(42):4566-4568.
PMID: 39563750
In this article we comment on the article by Agatsuma . Our article focuses on the use of screening for colon cancer increases the likelihood of early diagnosis of colorectal...
3.
Weissman S, Aziz M, Bangolo A, Nagesh V, Aung H, Mathew M, et al.
World J Gastrointest Surg
. 2024 Jul;
16(6):1835-1844.
PMID: 38983343
Background: Data regarding the worldwide gastrointestinal surgery rates in patients with Crohn's disease (CD) remains limited. Aim: To systematically review the global variation in the rates of surgery in CD....
4.
Flynn D, Feuerstein J
Ann Intern Med
. 2024 Jun;
177(6):JC69.
PMID: 38830221
Goltstein LC, Grooteman KV, Bernts LH, et al. Gastroenterology. 2024;166:690-703. 38158089.
5.
Hakim A, Feuerstein J
Ann Intern Med
. 2024 Mar;
177(3):JC32.
PMID: 38437700
Chen H, Wu S, Tang M, et al. N Engl J Med. 2023;389:1649-1659. 37913505.
6.
Sofia M, Feuerstein J, Narramore L, Chachu K, Streett S
Clin Gastroenterol Hepatol
. 2024 Mar;
22(5):944-955.
PMID: 38428707
Despite incredible growth in systems of care and rapidly expanding therapeutic options for people with inflammatory bowel disease, there are significant barriers that prevent patients from benefiting from these advances....
7.
Anderson K, Anand R, Feuerstein J
Am J Gastroenterol
. 2024 Feb;
PMID: 38417043
Introduction: Moderate-to-severe inflammatory bowel disease treatment transitioned from step-up therapy to induction of remission with a biologic agent, but insurance coverage varies. Methods: Top 50 insurance companies were searched for...
8.
Hakim A, Fricker Z, Feuerstein J, Farber H, Schoenberg N
Ann Intern Med
. 2024 Jan;
177(1):115-117.
PMID: 38163372
No abstract available.
9.
El-Dallal M, Anderson K, Saroufim A, Wang L, Systrom H, Hoque A, et al.
Ann Gastroenterol
. 2023 Nov;
36(6):624-629.
PMID: 38023973
Background: As marijuana use is rising among patients with inflammatory bowel disease (IBD), so is interest in its potential use as a therapeutic agent. We sought to survey IBD patients...
10.
Dong J, Said H, Miller S, Systrom H, Feuerstein J
J Clin Gastroenterol
. 2023 Nov;
58(8):805-809.
PMID: 38019086
Goals: The aim was to assess patient adherence to multitarget stool DNA testing as well as factors associated with adherence. Background: In the United States, disparities in colorectal cancer screening...